Report error Found 262 Enz. Inhib. hit(s) with all data for entry = 13510
TargetMucosa-associated lymphoid tissue lymphoma translocation protein 1(Human)
Hotspot Therapeutics
US Patent
Hotspot Therapeutics
US Patent
Affinity DataIC50: 500nMAssay Description:The standard reagent formulations used in this assay were prepared and stored as follows. A 1.1 M solution of sodium citrate (161.3 g, 500 mL) was pr...More data for this Ligand-Target Pair
TargetMucosa-associated lymphoid tissue lymphoma translocation protein 1(Human)
Hotspot Therapeutics
US Patent
Hotspot Therapeutics
US Patent
Affinity DataIC50: 500nMAssay Description:The standard reagent formulations used in this assay were prepared and stored as follows. A 1.1 M solution of sodium citrate (161.3 g, 500 mL) was pr...More data for this Ligand-Target Pair
TargetMucosa-associated lymphoid tissue lymphoma translocation protein 1(Human)
Hotspot Therapeutics
US Patent
Hotspot Therapeutics
US Patent
Affinity DataIC50: 500nMAssay Description:The standard reagent formulations used in this assay were prepared and stored as follows. A 1.1 M solution of sodium citrate (161.3 g, 500 mL) was pr...More data for this Ligand-Target Pair
TargetMucosa-associated lymphoid tissue lymphoma translocation protein 1(Human)
Hotspot Therapeutics
US Patent
Hotspot Therapeutics
US Patent
Affinity DataIC50: 500nMAssay Description:The standard reagent formulations used in this assay were prepared and stored as follows. A 1.1 M solution of sodium citrate (161.3 g, 500 mL) was pr...More data for this Ligand-Target Pair
TargetMucosa-associated lymphoid tissue lymphoma translocation protein 1(Human)
Hotspot Therapeutics
US Patent
Hotspot Therapeutics
US Patent
Affinity DataIC50: 500nMAssay Description:The standard reagent formulations used in this assay were prepared and stored as follows. A 1.1 M solution of sodium citrate (161.3 g, 500 mL) was pr...More data for this Ligand-Target Pair
TargetMucosa-associated lymphoid tissue lymphoma translocation protein 1(Human)
Hotspot Therapeutics
US Patent
Hotspot Therapeutics
US Patent
Affinity DataIC50: 500nMAssay Description:The standard reagent formulations used in this assay were prepared and stored as follows. A 1.1 M solution of sodium citrate (161.3 g, 500 mL) was pr...More data for this Ligand-Target Pair
TargetMucosa-associated lymphoid tissue lymphoma translocation protein 1(Human)
Hotspot Therapeutics
US Patent
Hotspot Therapeutics
US Patent
Affinity DataIC50: 500nMAssay Description:The standard reagent formulations used in this assay were prepared and stored as follows. A 1.1 M solution of sodium citrate (161.3 g, 500 mL) was pr...More data for this Ligand-Target Pair
TargetMucosa-associated lymphoid tissue lymphoma translocation protein 1(Human)
Hotspot Therapeutics
US Patent
Hotspot Therapeutics
US Patent
Affinity DataIC50: 500nMAssay Description:The standard reagent formulations used in this assay were prepared and stored as follows. A 1.1 M solution of sodium citrate (161.3 g, 500 mL) was pr...More data for this Ligand-Target Pair
TargetMucosa-associated lymphoid tissue lymphoma translocation protein 1(Human)
Hotspot Therapeutics
US Patent
Hotspot Therapeutics
US Patent
Affinity DataIC50: 500nMAssay Description:The standard reagent formulations used in this assay were prepared and stored as follows. A 1.1 M solution of sodium citrate (161.3 g, 500 mL) was pr...More data for this Ligand-Target Pair
TargetMucosa-associated lymphoid tissue lymphoma translocation protein 1(Human)
Hotspot Therapeutics
US Patent
Hotspot Therapeutics
US Patent
Affinity DataIC50: 500nMAssay Description:The standard reagent formulations used in this assay were prepared and stored as follows. A 1.1 M solution of sodium citrate (161.3 g, 500 mL) was pr...More data for this Ligand-Target Pair
TargetMucosa-associated lymphoid tissue lymphoma translocation protein 1(Human)
Hotspot Therapeutics
US Patent
Hotspot Therapeutics
US Patent
Affinity DataIC50: 500nMAssay Description:The standard reagent formulations used in this assay were prepared and stored as follows. A 1.1 M solution of sodium citrate (161.3 g, 500 mL) was pr...More data for this Ligand-Target Pair
TargetMucosa-associated lymphoid tissue lymphoma translocation protein 1(Human)
Hotspot Therapeutics
US Patent
Hotspot Therapeutics
US Patent
Affinity DataIC50: 500nMAssay Description:The standard reagent formulations used in this assay were prepared and stored as follows. A 1.1 M solution of sodium citrate (161.3 g, 500 mL) was pr...More data for this Ligand-Target Pair
TargetMucosa-associated lymphoid tissue lymphoma translocation protein 1(Human)
Hotspot Therapeutics
US Patent
Hotspot Therapeutics
US Patent
Affinity DataIC50: 500nMAssay Description:The standard reagent formulations used in this assay were prepared and stored as follows. A 1.1 M solution of sodium citrate (161.3 g, 500 mL) was pr...More data for this Ligand-Target Pair
TargetMucosa-associated lymphoid tissue lymphoma translocation protein 1(Human)
Hotspot Therapeutics
US Patent
Hotspot Therapeutics
US Patent
Affinity DataIC50: 500nMAssay Description:The standard reagent formulations used in this assay were prepared and stored as follows. A 1.1 M solution of sodium citrate (161.3 g, 500 mL) was pr...More data for this Ligand-Target Pair
TargetMucosa-associated lymphoid tissue lymphoma translocation protein 1(Human)
Hotspot Therapeutics
US Patent
Hotspot Therapeutics
US Patent
Affinity DataIC50: 500nMAssay Description:The standard reagent formulations used in this assay were prepared and stored as follows. A 1.1 M solution of sodium citrate (161.3 g, 500 mL) was pr...More data for this Ligand-Target Pair
TargetMucosa-associated lymphoid tissue lymphoma translocation protein 1(Human)
Hotspot Therapeutics
US Patent
Hotspot Therapeutics
US Patent
Affinity DataIC50: 500nMAssay Description:The standard reagent formulations used in this assay were prepared and stored as follows. A 1.1 M solution of sodium citrate (161.3 g, 500 mL) was pr...More data for this Ligand-Target Pair
TargetMucosa-associated lymphoid tissue lymphoma translocation protein 1(Human)
Hotspot Therapeutics
US Patent
Hotspot Therapeutics
US Patent
Affinity DataIC50: 500nMAssay Description:The standard reagent formulations used in this assay were prepared and stored as follows. A 1.1 M solution of sodium citrate (161.3 g, 500 mL) was pr...More data for this Ligand-Target Pair
TargetMucosa-associated lymphoid tissue lymphoma translocation protein 1(Human)
Hotspot Therapeutics
US Patent
Hotspot Therapeutics
US Patent
Affinity DataIC50: 500nMAssay Description:The standard reagent formulations used in this assay were prepared and stored as follows. A 1.1 M solution of sodium citrate (161.3 g, 500 mL) was pr...More data for this Ligand-Target Pair
TargetMucosa-associated lymphoid tissue lymphoma translocation protein 1(Human)
Hotspot Therapeutics
US Patent
Hotspot Therapeutics
US Patent
Affinity DataIC50: 500nMAssay Description:The standard reagent formulations used in this assay were prepared and stored as follows. A 1.1 M solution of sodium citrate (161.3 g, 500 mL) was pr...More data for this Ligand-Target Pair
TargetMucosa-associated lymphoid tissue lymphoma translocation protein 1(Human)
Hotspot Therapeutics
US Patent
Hotspot Therapeutics
US Patent
Affinity DataIC50: 500nMAssay Description:The standard reagent formulations used in this assay were prepared and stored as follows. A 1.1 M solution of sodium citrate (161.3 g, 500 mL) was pr...More data for this Ligand-Target Pair
TargetMucosa-associated lymphoid tissue lymphoma translocation protein 1(Human)
Hotspot Therapeutics
US Patent
Hotspot Therapeutics
US Patent
Affinity DataIC50: 500nMAssay Description:The standard reagent formulations used in this assay were prepared and stored as follows. A 1.1 M solution of sodium citrate (161.3 g, 500 mL) was pr...More data for this Ligand-Target Pair
TargetMucosa-associated lymphoid tissue lymphoma translocation protein 1(Human)
Hotspot Therapeutics
US Patent
Hotspot Therapeutics
US Patent
Affinity DataIC50: 500nMAssay Description:The standard reagent formulations used in this assay were prepared and stored as follows. A 1.1 M solution of sodium citrate (161.3 g, 500 mL) was pr...More data for this Ligand-Target Pair
TargetMucosa-associated lymphoid tissue lymphoma translocation protein 1(Human)
Hotspot Therapeutics
US Patent
Hotspot Therapeutics
US Patent
Affinity DataIC50: 500nMAssay Description:The standard reagent formulations used in this assay were prepared and stored as follows. A 1.1 M solution of sodium citrate (161.3 g, 500 mL) was pr...More data for this Ligand-Target Pair
TargetMucosa-associated lymphoid tissue lymphoma translocation protein 1(Human)
Hotspot Therapeutics
US Patent
Hotspot Therapeutics
US Patent
Affinity DataIC50: 500nMAssay Description:The standard reagent formulations used in this assay were prepared and stored as follows. A 1.1 M solution of sodium citrate (161.3 g, 500 mL) was pr...More data for this Ligand-Target Pair
TargetMucosa-associated lymphoid tissue lymphoma translocation protein 1(Human)
Hotspot Therapeutics
US Patent
Hotspot Therapeutics
US Patent
Affinity DataIC50: 500nMAssay Description:The standard reagent formulations used in this assay were prepared and stored as follows. A 1.1 M solution of sodium citrate (161.3 g, 500 mL) was pr...More data for this Ligand-Target Pair
TargetMucosa-associated lymphoid tissue lymphoma translocation protein 1(Human)
Hotspot Therapeutics
US Patent
Hotspot Therapeutics
US Patent
Affinity DataIC50: 500nMAssay Description:The standard reagent formulations used in this assay were prepared and stored as follows. A 1.1 M solution of sodium citrate (161.3 g, 500 mL) was pr...More data for this Ligand-Target Pair
TargetMucosa-associated lymphoid tissue lymphoma translocation protein 1(Human)
Hotspot Therapeutics
US Patent
Hotspot Therapeutics
US Patent
Affinity DataIC50: 500nMAssay Description:The standard reagent formulations used in this assay were prepared and stored as follows. A 1.1 M solution of sodium citrate (161.3 g, 500 mL) was pr...More data for this Ligand-Target Pair
TargetMucosa-associated lymphoid tissue lymphoma translocation protein 1(Human)
Hotspot Therapeutics
US Patent
Hotspot Therapeutics
US Patent
Affinity DataIC50: 500nMAssay Description:The standard reagent formulations used in this assay were prepared and stored as follows. A 1.1 M solution of sodium citrate (161.3 g, 500 mL) was pr...More data for this Ligand-Target Pair
TargetMucosa-associated lymphoid tissue lymphoma translocation protein 1(Human)
Hotspot Therapeutics
US Patent
Hotspot Therapeutics
US Patent
Affinity DataIC50: 500nMAssay Description:The standard reagent formulations used in this assay were prepared and stored as follows. A 1.1 M solution of sodium citrate (161.3 g, 500 mL) was pr...More data for this Ligand-Target Pair
TargetMucosa-associated lymphoid tissue lymphoma translocation protein 1(Human)
Hotspot Therapeutics
US Patent
Hotspot Therapeutics
US Patent
Affinity DataIC50: 500nMAssay Description:The standard reagent formulations used in this assay were prepared and stored as follows. A 1.1 M solution of sodium citrate (161.3 g, 500 mL) was pr...More data for this Ligand-Target Pair
TargetMucosa-associated lymphoid tissue lymphoma translocation protein 1(Human)
Hotspot Therapeutics
US Patent
Hotspot Therapeutics
US Patent
Affinity DataIC50: 500nMAssay Description:The standard reagent formulations used in this assay were prepared and stored as follows. A 1.1 M solution of sodium citrate (161.3 g, 500 mL) was pr...More data for this Ligand-Target Pair
TargetMucosa-associated lymphoid tissue lymphoma translocation protein 1(Human)
Hotspot Therapeutics
US Patent
Hotspot Therapeutics
US Patent
Affinity DataIC50: 500nMAssay Description:The standard reagent formulations used in this assay were prepared and stored as follows. A 1.1 M solution of sodium citrate (161.3 g, 500 mL) was pr...More data for this Ligand-Target Pair
TargetMucosa-associated lymphoid tissue lymphoma translocation protein 1(Human)
Hotspot Therapeutics
US Patent
Hotspot Therapeutics
US Patent
Affinity DataIC50: 500nMAssay Description:The standard reagent formulations used in this assay were prepared and stored as follows. A 1.1 M solution of sodium citrate (161.3 g, 500 mL) was pr...More data for this Ligand-Target Pair
TargetMucosa-associated lymphoid tissue lymphoma translocation protein 1(Human)
Hotspot Therapeutics
US Patent
Hotspot Therapeutics
US Patent
Affinity DataIC50: 500nMAssay Description:The standard reagent formulations used in this assay were prepared and stored as follows. A 1.1 M solution of sodium citrate (161.3 g, 500 mL) was pr...More data for this Ligand-Target Pair
TargetMucosa-associated lymphoid tissue lymphoma translocation protein 1(Human)
Hotspot Therapeutics
US Patent
Hotspot Therapeutics
US Patent
Affinity DataIC50: 500nMAssay Description:The standard reagent formulations used in this assay were prepared and stored as follows. A 1.1 M solution of sodium citrate (161.3 g, 500 mL) was pr...More data for this Ligand-Target Pair
TargetMucosa-associated lymphoid tissue lymphoma translocation protein 1(Human)
Hotspot Therapeutics
US Patent
Hotspot Therapeutics
US Patent
Affinity DataIC50: 500nMAssay Description:The standard reagent formulations used in this assay were prepared and stored as follows. A 1.1 M solution of sodium citrate (161.3 g, 500 mL) was pr...More data for this Ligand-Target Pair
TargetMucosa-associated lymphoid tissue lymphoma translocation protein 1(Human)
Hotspot Therapeutics
US Patent
Hotspot Therapeutics
US Patent
Affinity DataIC50: 500nMAssay Description:The standard reagent formulations used in this assay were prepared and stored as follows. A 1.1 M solution of sodium citrate (161.3 g, 500 mL) was pr...More data for this Ligand-Target Pair
TargetMucosa-associated lymphoid tissue lymphoma translocation protein 1(Human)
Hotspot Therapeutics
US Patent
Hotspot Therapeutics
US Patent
Affinity DataIC50: 500nMAssay Description:The standard reagent formulations used in this assay were prepared and stored as follows. A 1.1 M solution of sodium citrate (161.3 g, 500 mL) was pr...More data for this Ligand-Target Pair
TargetMucosa-associated lymphoid tissue lymphoma translocation protein 1(Human)
Hotspot Therapeutics
US Patent
Hotspot Therapeutics
US Patent
Affinity DataIC50: 500nMAssay Description:The standard reagent formulations used in this assay were prepared and stored as follows. A 1.1 M solution of sodium citrate (161.3 g, 500 mL) was pr...More data for this Ligand-Target Pair
TargetMucosa-associated lymphoid tissue lymphoma translocation protein 1(Human)
Hotspot Therapeutics
US Patent
Hotspot Therapeutics
US Patent
Affinity DataIC50: 500nMAssay Description:The standard reagent formulations used in this assay were prepared and stored as follows. A 1.1 M solution of sodium citrate (161.3 g, 500 mL) was pr...More data for this Ligand-Target Pair
TargetMucosa-associated lymphoid tissue lymphoma translocation protein 1(Human)
Hotspot Therapeutics
US Patent
Hotspot Therapeutics
US Patent
Affinity DataIC50: 500nMAssay Description:The standard reagent formulations used in this assay were prepared and stored as follows. A 1.1 M solution of sodium citrate (161.3 g, 500 mL) was pr...More data for this Ligand-Target Pair
TargetMucosa-associated lymphoid tissue lymphoma translocation protein 1(Human)
Hotspot Therapeutics
US Patent
Hotspot Therapeutics
US Patent
Affinity DataIC50: 500nMAssay Description:The standard reagent formulations used in this assay were prepared and stored as follows. A 1.1 M solution of sodium citrate (161.3 g, 500 mL) was pr...More data for this Ligand-Target Pair
TargetMucosa-associated lymphoid tissue lymphoma translocation protein 1(Human)
Hotspot Therapeutics
US Patent
Hotspot Therapeutics
US Patent
Affinity DataIC50: 500nMAssay Description:The standard reagent formulations used in this assay were prepared and stored as follows. A 1.1 M solution of sodium citrate (161.3 g, 500 mL) was pr...More data for this Ligand-Target Pair
TargetMucosa-associated lymphoid tissue lymphoma translocation protein 1(Human)
Hotspot Therapeutics
US Patent
Hotspot Therapeutics
US Patent
Affinity DataIC50: 500nMAssay Description:The standard reagent formulations used in this assay were prepared and stored as follows. A 1.1 M solution of sodium citrate (161.3 g, 500 mL) was pr...More data for this Ligand-Target Pair
TargetMucosa-associated lymphoid tissue lymphoma translocation protein 1(Human)
Hotspot Therapeutics
US Patent
Hotspot Therapeutics
US Patent
Affinity DataIC50: 500nMAssay Description:The standard reagent formulations used in this assay were prepared and stored as follows. A 1.1 M solution of sodium citrate (161.3 g, 500 mL) was pr...More data for this Ligand-Target Pair
TargetMucosa-associated lymphoid tissue lymphoma translocation protein 1(Human)
Hotspot Therapeutics
US Patent
Hotspot Therapeutics
US Patent
Affinity DataIC50: 500nMAssay Description:The standard reagent formulations used in this assay were prepared and stored as follows. A 1.1 M solution of sodium citrate (161.3 g, 500 mL) was pr...More data for this Ligand-Target Pair
TargetMucosa-associated lymphoid tissue lymphoma translocation protein 1(Human)
Hotspot Therapeutics
US Patent
Hotspot Therapeutics
US Patent
Affinity DataIC50: 500nMAssay Description:The standard reagent formulations used in this assay were prepared and stored as follows. A 1.1 M solution of sodium citrate (161.3 g, 500 mL) was pr...More data for this Ligand-Target Pair
TargetMucosa-associated lymphoid tissue lymphoma translocation protein 1(Human)
Hotspot Therapeutics
US Patent
Hotspot Therapeutics
US Patent
Affinity DataIC50: 500nMAssay Description:The standard reagent formulations used in this assay were prepared and stored as follows. A 1.1 M solution of sodium citrate (161.3 g, 500 mL) was pr...More data for this Ligand-Target Pair
TargetMucosa-associated lymphoid tissue lymphoma translocation protein 1(Human)
Hotspot Therapeutics
US Patent
Hotspot Therapeutics
US Patent
Affinity DataIC50: 500nMAssay Description:The standard reagent formulations used in this assay were prepared and stored as follows. A 1.1 M solution of sodium citrate (161.3 g, 500 mL) was pr...More data for this Ligand-Target Pair
TargetMucosa-associated lymphoid tissue lymphoma translocation protein 1(Human)
Hotspot Therapeutics
US Patent
Hotspot Therapeutics
US Patent
Affinity DataIC50: 500nMAssay Description:The standard reagent formulations used in this assay were prepared and stored as follows. A 1.1 M solution of sodium citrate (161.3 g, 500 mL) was pr...More data for this Ligand-Target Pair

















































